Main Sequence Ventures
Phil Morle is a Director at ULUU and has been a Partner at Main Sequence Ventures since June 2017. Phil is also the Chair at Eden Brew, Samsara Eco, v2food, Nourish Ingredients, and serves as a Director at Coviu Global, Q-CTRL, Maxwell Plus, and Pollenizer. Phil co-founded Pollenizer in 2008 and currently serves as the CEO, focusing on coaching startup founders. Phil holds a BA (Hons) in Performing Arts from Northumbria University.
Main Sequence Ventures
2 followers
We are Australia’s deep tech investment fund tackling the world’s biggest challenges by turning today’s scientific discoveries into tomorrow’s industries. Main Sequence works closely with scientists, researchers and industry collaborators to create, fund and accelerate new companies and industries that accelerate humanity for a more prosperous future. Main Sequence was set up in 2017 to manage the CSIRO Innovation Fund, founded by the Australian Government and the national science agency to reinvest its historic contributions into the successes of the future. Over the past four years, Main Sequence has invested in 39 companies changing the way healthcare is delivered, food is produced, spaces are connected and more. These investments have led to more than 60 company collaborative projects with universities and 19 projects with CSIRO.